Research map: Virtual special section: Gut microbiota in drug metabolism
Back to the article
Papers in this map
Mapping human microbiome drug metabolism by gut bacteria and their genes
· Michael Bruce Zimmermann · 2019 · 1179 citations · Cited by this paper
A 3-step static mechanistic modeling approach to predicting transporter- and enzyme-mediated interaction signals of direct oral anticoagulants
· 2026 · Related
Alleviating Cancer Drug Toxicity by Inhibiting a Bacterial Enzyme
· Bret D. Wallace · 2010 · 1069 citations · Cited by this paper
Investigation of biomarkers for azole antifungal-induced liver injury using primary human hepatocyte spheroids
· 2026 · Related
Predicting and Manipulating Cardiac Drug Inactivation by the Human Gut Bacterium Eggerthella lenta
· Henry J. Haiser · 2013 · 711 citations · Cited by this paper
Physiologically based pharmacokinetic modeling of the unusual kinetics of ketoconazole due to nonlinear liver binding and metabolism in rats
· 2026 · Related
An Atlas of β-Glucuronidases in the Human Intestinal Microbiome
· Rebecca M. Pollet · 2017 · 293 citations · Cited by this paper
Role of CYP3A5 and CYP3A4 in the metabolism and toxicity of 10-hydroxyl mesaconitine, a new potential toxicity marker of Radix Aconiti Lateralis Preparata (Fuzi), in vitro and in vivo
· 2026 · Related
Commensal Gut Bacteria Convert the Immunosuppressant Tacrolimus to Less Potent Metabolites
· Yukuang Guo · 2018 · 162 citations · Cited by this paper
Mechanistically resolved prediction of compound hepatotoxicity using primary human liver spheroids—Application to recent real-world cases
· 2026 · Related
Gut Microbiome Integration in Drug Discovery and Development of Small Molecules
· Patrick Jimonet · 2024 · 19 citations · Cited by this paper
A comprehensive investigation into the effect of bisphenol A on the expression of drug-metabolizing enzymes: Consequences for endogenous metabolites and xenobiotic pharmacokinetics
· 2026 · Related
In vitro metabolism of targeted covalent inhibitors and their thiol conjugates by gut microbiome from rats, mice, and humans
· Ting‐Jia Gu · 2024 · 7 citations · Cited by this paper
Mechanistic Study on the Species Differences in Metabolism and Excretion Pathways of Ivarmacitinib (SHR0302) between Humans and Rats
· 2026 · Related
The impact of progressive chronic kidney disease on hepatic drug metabolism
· Emily D. Hartjes · 2025 · 6 citations · Cited by this paper
PSMD2 mediates the degradation of CYP1A2 and promotes the progression of metabolic dysfunction-associated steatohepatitis
· 2026 · Related
Discovery of Unprecedented Human Stercobilin Conjugates
· Sungjoon Cho · 2024 · 5 citations · Cited by this paper
Diagnostic exogenous probe strategy using ezetimibe-glucuronide effectively identifies metabolic dysfunction–associated steatohepatitis
· 2026 · Related
Hydrolysis of O-, N-, and N+-glucuronide metabolites in human feces
· Zhoupeng Zhang · 2025 · 4 citations · Cited by this paper
Absorption, metabolism, and excretion of single dose oral [14C]camizestrant in healthy human female participants
· 2026 · Related
Characterization of fecal deglucuronidation activity in healthy subjects and in patients treated with fecal microbiota transplantation
· Arttu Uoti · 2025 · 2 citations · Cited by this paper
Impact of the gut microbiome on hepatic cytochrome P450 3A4 (CYP3A4) in humanized pregnane X receptor-constitutive androstane receptor-CYP3A4/3A7 mice
· Jennifer Liem · 2026 · 2 citations · Cited by this paper
The anti-inflammatory drug celecoxib is metabolized by Pseudomonas aeruginosa CYP107S1 in vitro and in vivo
· Sylvie E. Kandel · 2025 · 1 citation · Cited by this paper
Gut microbial resistance and metabolism of selective serotonin reuptake inhibitors drive multidrug resistance and contribute to antidepressant tachyphylaxis
· Ming-Che Cheng · 2026 · 1 citation · Cited by this paper
Source: OpenAlex (CC0)